You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

DRISDOL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Drisdol patents expire, and when can generic versions of Drisdol launch?

Drisdol is a drug marketed by Ss Pharma and is included in one NDA.

The generic ingredient in DRISDOL is ergocalciferol. There are six drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the ergocalciferol profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Drisdol

A generic version of DRISDOL was approved as ergocalciferol by CHARTWELL RX on May 20th, 2009.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DRISDOL?
  • What are the global sales for DRISDOL?
  • What is Average Wholesale Price for DRISDOL?
Summary for DRISDOL
US Patents:0
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 82
Clinical Trials: 5
Patent Applications: 3,434
What excipients (inactive ingredients) are in DRISDOL?DRISDOL excipients list
DailyMed Link:DRISDOL at DailyMed
Drug patent expirations by year for DRISDOL
Drug Sales Revenue Trends for DRISDOL

See drug sales revenues for DRISDOL

Recent Clinical Trials for DRISDOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Wake Forest University Health SciencesEarly Phase 1
Albany College of Pharmacy and Health SciencesPhase 4
Hortense & Louis Rubin Dialysis CenterPhase 4

See all DRISDOL clinical trials

Pharmacology for DRISDOL

US Patents and Regulatory Information for DRISDOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ss Pharma DRISDOL ergocalciferol CAPSULE;ORAL 003444-001 Approved Prior to Jan 1, 1982 AA RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.